Special Issue "Cancer Care during COVID-19 Pandemic"

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Palliative and Supportive Care".

Deadline for manuscript submissions: 31 August 2021.

Special Issue Editor

Prof. Dr. Shahid Ahmed
E-Mail Website
Guest Editor
College of Medicine, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada
Interests: clinical trial; population health; breast cancer; gastrointestinal cancers

Special Issue Information

Dear Colleagues, 

The COVID-19 pandemic is an unprecedented global event in modern medical history that has resulted in overwhelmed health care systems in many countries. As of the end of 2020, it has infected more than 80 million people and has taken the lives of about 2 million people. Cancer patients are particularly at higher risk of severe COVID-19 infection. In response to the challenges related to the COVID-19 outbreak, cancer care facilities and jurisdictions have rapidly adapted and modified their services to sustain safe cancer care, including the implementation of telemedicine services and virtual care. However, due to overwhelmed health care systems in several jurisdictions, there have been delays in oncologic surgery, (neo)adjuvant therapy or definite chemoradiation that could result in inferior outcomes. Experience of treating cancer patients during this pandemic will likely have much lasting effect on cancer care. Primary prevention with vaccine is one of the most effective interventions to reduce COVID-19 infection and morbidities and mortality associated with the disease. Currently, there are more than 50 COVID-19 vaccine candidates in clinical trials and a few of them have received approval for their use in a healthy population.

In response to COVID-related challenges in cancer patient care, Current Oncology plans to publish a Special Issue on COVID-19. We are pleased to invite you to make contribution in the Special Issue on COVID-19 and Cancer care. This issue aims to publish original articles and systemic reviews addressing the impact of the COVID19 pandemic on the continuum of cancer care, including cancer screening, diagnostics, therapeutics, surveillance, and supportive care, cancer outcomes, and the mental health of cancer patients, as well as research into the COVID-19 vaccine in cancer patients. I look forward to receiving your contributions.  

Prof. Dr. Shahid Ahmed
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • COVID-19
  • corona virus
  • pandemic
  • cancer care
  • cancer treatment
  • COVID-19 vaccine
  • mental health
  • cancer outcomes
  • cancer screening
  • virtual care

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Open AccessArticle
Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience
Curr. Oncol. 2021, 28(2), 1507-1517; https://doi.org/10.3390/curroncol28020142 - 10 Apr 2021
Viewed by 415
Abstract
The COVID-19 pandemic has shifted oncology practices to prioritize patient safety while maintaining necessary treatment delivery. We obtained patient feedback on pandemic-based practices in our radiotherapy department to improve quality of patient care and amend policies as needed. We developed a piloted questionnaire [...] Read more.
The COVID-19 pandemic has shifted oncology practices to prioritize patient safety while maintaining necessary treatment delivery. We obtained patient feedback on pandemic-based practices in our radiotherapy department to improve quality of patient care and amend policies as needed. We developed a piloted questionnaire which quantitatively and qualitatively assessed patients’ pandemic-related concerns and satisfaction with specific elements of their care. Adult patients who were treated at our Centre between 23 March and 31 May 2020, had initial consultation via telemedicine, and received at least five outpatient fractions of radiotherapy were invited to complete the survey by telephone or online. Relative frequencies of categorical and ordinal responses were then calculated. Fifty-three (48%) out of 110 eligible patients responded: 32 patients by phone and 21 patients online. Eighteen participants (34%) admitted to feeling anxious about hospital appointments, and only five (9%) reported treatment delays. Forty-eight patients (91%) reported satisfaction with their initial telemedicine appointment. The majority of patients indicated that healthcare workers took appropriate precautions, making them feel safe. Overall, all 53 patients (100%) reported being satisfied with their treatment experience during the pandemic. Patient feedback is needed to provide the highest quality of patient care as we adapt to the current reality. Full article
(This article belongs to the Special Issue Cancer Care during COVID-19 Pandemic)
Show Figures

Figure 1

Back to TopTop